Work

The Tol2 transposon system mediates the genetic engineering of T-cells with CD19-specific chimeric antigen receptors for B-cell malignancies

Year: 2014

Type: article

Source: Gene Therapy

DOI: 10.1038/gt.2014.104

Authors: T Tsukahara, N Iwase, K Kawakami, M Iwasaki, C Yamamoto, K Ohmine, R Uchibori, T Teruya, H Ido, Y Saga, M Urabe, H Mizukami, A Kume, M Nakamura, R Brentjens, K Ozawa

Institutions: Jichi Medical University, National Institute of Genetics, Tokyo Medical and Dental University, Memorial Sloan Kettering Cancer Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Ministry of Education, Culture, Sports, Science and Technology, Japan Society for the Promotion of Science, National Cancer Institute

Awards: Development of immunogene therapy using T-cells expressing a chimeric antigen receptor for adult T-cell leukemia, Establishment of a basis to study vertebrate phoneme based on transposon-mediated genetic methods, Cancer Center Support Grant

OpenAlex ID: W2050002181

FWCI: 1.802

Cites: 38

Cited by: 35

Related to: 10